IBBQ
IBBQ
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) seeks to mirror the investment performance of the Nasdaq Biotechnology Index. To achieve this, the Fund generally dedicates at least 90% of its total capital to the securities that make up this benchmark index. The underlying Index itself is specifically designed to gauge the returns of biotechnology and pharmaceutical companies whose shares are...
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) seeks to mirror the investment performance of the Nasdaq Biotechnology Index. To achieve this, the Fund generally dedicates at least 90% of its total capital to the securities that make up this benchmark index. The underlying Index itself is specifically designed to gauge the returns of biotechnology and pharmaceutical companies whose shares are...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 VRTX | Vertex Pharmaceuticals Incorporated | 7.89% | 12.08K | $5.80M |
 AMGN | Amgen Inc. | 7.87% | 16.06K | $5.79M |
 GILD | Gilead Sciences, Inc. | 7.19% | 40.23K | $5.29M |
 REGN | Regeneron Pharmaceuticals, Inc. | 4.79% | 5.32K | $3.52M |
 RVMD | Revolution Medicines, Inc. | 2.74% | 10.97K | $2.02M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 2.70% | 6.88K | $1.98M |
 BIIB | Biogen Inc. | 2.16% | 7.62K | $1.59M |
 ILMN | Illumina, Inc. | 2.02% | 7.80K | $1.48M |
 MRNA | Moderna, Inc. | 1.86% | 20.47K | $1.37M |
 RPRX | Royalty Pharma plc | 1.75% | 22.86K | $1.29M |
 ROIV | Roivant Sciences Ltd. | 1.74% | 37.10K | $1.28M |
 INSM | Insmed Incorporated | 1.66% | 11.18K | $1.22M |
 INCY | Incyte Corporation | 1.60% | 10.31K | $1.18M |
 UTHR | United Therapeutics Corporation | 1.59% | 2.19K | $1.17M |
 GH | Guardant Health, Inc. | 1.47% | 6.84K | $1.08M |
 VTRS | Viatris Inc. | 1.34% | 60.07K | $984.50K |
 NBIX | Neurocrine Biosciences, Inc. | 1.23% | 5.19K | $902.88K |
 ASND | Ascendis Pharma A/S | 1.14% | 3.17K | $842.07K |
 BBIO | BridgeBio Pharma, Inc. | 1.14% | 10.10K | $839.36K |
 MEDP | Medpace Holdings, Inc. | 1.06% | 1.48K | $782.03K |
SECTOR HOLDINGS
Healthcare
Cash & Others
Consumer Cyclical
IndustrialsASSET ALLOCATION BY REGION
United States
United Kingdom
Netherlands
Ireland
Denmark
France
Switzerland
Canada
Germany
Singapore
Luxembourg
Spain
Australia
China
Belgium
Israel
TaiwanSECTOR HOLDINGS
Healthcare Cash & Others Consumer Cyclical IndustrialsASSET ALLOCATION BY REGION
United States United Kingdom Netherlands Ireland Denmark France Switzerland Canada Germany Singapore Luxembourg Spain Australia China Belgium Israel TaiwanHoldings (Top 20)
VRTX
Vertex Pharmaceuticals Incorporated
AMGN
Amgen Inc.
GILD
Gilead Sciences, Inc.
REGN
Regeneron Pharmaceuticals, Inc.
RVMD
Revolution Medicines, Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
BIIB
Biogen Inc.
ILMN
Illumina, Inc.
MRNA
Moderna, Inc.
RPRX
Royalty Pharma plc
ROIV
Roivant Sciences Ltd.
INSM
Insmed Incorporated
INCY
Incyte Corporation
UTHR
United Therapeutics Corporation
GH
Guardant Health, Inc.
VTRS
Viatris Inc.
NBIX
Neurocrine Biosciences, Inc.
ASND
Ascendis Pharma A/S
BBIO
BridgeBio Pharma, Inc.
MEDP
Medpace Holdings, Inc.